Betreff: Brain & Nervous System Cancers..Seattle Cancer Care Alliance..10 06
Datum: Sun, 22 Oct 2006 12:34:12 EDT

The great job you are doing disseminating EMF/EMR concerns continues!!!!   You are providing an invaluable service to society and your efforts are yielding results beyond that which are immediately known. 
I was not able to locate information regarding EMF/EMR on the SCCA site re Leukemia, however, as you can see, "electromagnetic fields" are listed as possible environmental link to brain and nervous system cancers.
Interesting also is the reference to the chemical exposures and possible in-utero or early infancy link.  Studies and evaluations of "in-utero exposures" are important, of course,  but I believe a focus on "in-utero exposures" may seriously delay identification of many life-threatening situations for countless vulnerable infants and children.  We know too that the elderly are at increased risk and effects of medications are most likely compromised.
As you know, both of my infant grandsons -- later diagnosed (toddler ages) with rare immune deficiencies (we were told they may develop Leukemia, Lymphoma or other cancers) --  were placed safely and securely in warm, comfortable cribs located close to electric meters in their respective homes.  They were being killed with kindness -- their moms' and dads' didn't know about the "danger(s) behind the wall(s).........."  
Since both boys' overall IGG's increased  significantly at time of next blood tests several months after moving their beds away from "powerwalls," one could consider such a move as "treatment."  Dr. Gerald Goldberg, author of "Would You Put Your Head in A Microwave" confirmed this theory during a phone conversation a couple of weeks ago.  [ Access to a radio interview of Dr. Goldberg can be made via .]
Guinea pigs placed against powerwall in my home developed blood changes that can be defined as "pre-Leukemic and are well-known "markers for irradiation."  Survivors "improved" after moving cages.
BauBiologist Oram Miller  ( )  provides information regarding need to check homes for possible wiring errors and grounding problems. An evaluation of this sort should be undertaken before considering turning bedroom circuits off at night.
In the interim, persons should move electric appliances off of nightstands and headboards -- electric clocks, electric clock radios, small fans, monitors, power supply boxes for cordless phones, touchlamps, lamps with dimmer switches, high intensity lamps, etc.  My husband's memory tests improved after moving his electric clock radio.
Our family has a 3-page list of health problems which include several rare and unusal findings.  The two high voltgage powerlines only 50 ft. from the front of our house, in addition to above-mentioned exposures are major concerns.  There are now also many cellular antennae within a mile or so of us.
Prof. Olle Johansson acknowledges the importance of identifying those low dose EMF/EMR exposures that yield results which correlate with known "markers for irradiation" in regard to low dose ionizing radiation exposures.  Only by first confirming white blood cell changes that occur during low dose EMF/EMR "close, chronic, prolonged exposures" at night, will meaningful conclusions ever be reached in regard to possible harmful effects from the more distant exposures. 
We await the necessary funding to be directed to the one scientist in the world with the courage, ability, integrity and overwhelming desire to " help "save the children!!!"
Thanks again for all of your hard work!!!   Best wishes and take care  -  Joanne
Joanne C. Mueller
Guinea Pigs R Us
731 - 123rd Avenue N.W.
Minneapolis, Minnesota  55448-2127 USA
Phone:   763-755-6114
Email:  (10-22-06)

"No substance is a poison by itself. It is the dose that makes a substance a poison..."  Paracelsus (1493-1541)

Betreff: Brain & Nervous System Cancers..Seattle Cancer Care Alliance..10 06
Datum: Sun, 22 Oct 2006 11:10:31 EDT

Seattle Cancer Care Alliance (SCCA) unites three internationally renowned cancer care institutions—Fred Hutchinson Cancer Research Center, UW Medicine, and Children’s Hospital and Regional Medical Center—to offer a variety of treatment options, designed from the latest research, for malignant and non-malignant diseases.   [Note reference to electromagnetic radiation in Brain & Nervous System Cancer portion of website.  10-22-06 jcm]

Contact Us:
Seattle Cancer Care Alliance
825 Eastlake Ave. E
P.O. Box 19023
Seattle, WA 98109-1023
(206) 288-7222



Brain & Nervous System

Patient Education

What are Brain and Nervous System Cancers?

Risk factors

  • Children and the elderly
  • Children cured of leukemia
  • Exposure to X-rays to the head for the purpose of treating diseases such as cancer. (Does not include dental X-rays.)
  • People with genetic abnormalities: researchers have identified several genetic abnormalities related to specific malignant brain tumors, e.g., a gain of one more copies of chromosome 7 is found in 80 percent of glioblastoma multiform tumors.
  • People with a history of brain tumors in their family. Currently, 5 percent of brain tumors are known to be associated with hereditary factors.
  • People with rare genetic disorders, including Li-Fraumeni syndrome (increased risk of glioma), tuberous sclerosis (increased risk of astrocytoma), von Hippel-Lindaul disease (increased risk of hemangioblastoma), neurofibromatosis type 1 or von Recklinghausen's disease (increased risk of glioma), and neurofibromatosis type 2 (increased risk of acoustic nerve tumor and meningioma).
  • Possible environmental links include electromagnetic fields, and several chemical agents: acrylonitrile, vinyl chloride, formaldehyde, lubricating oils, N-nitroso compounds, phenols, pesticides, polyclic aromatic hydrocarbons, and organic solvents. The industries most affected by these chemicals include synthetic rubber and polyvinyl chloride manufacturers, crude oil and petroleum-based chemical producers, pharmaceutical manufacturers, nuclear fuel and weapons producers, and farms that use agricultural chemicals. Studies with animals indicate that the greatest risk of experiencing ill effects of these chemicals is in utero or early infancy.
  • People with disorders of the immune system, including immune systems compromised due to treatment for cancer; people who have taken or are taking immunosuppressive drugs to prevent rejection of transplanted organs or cells; and people with AIDS, which increases the risk of lymphoma in the brain.

Symptoms Brain tumors cause a wide variety of symptoms, all of which could also be attributed to other diseases. The symptoms depend on the size of the tumor and its location. Common symptoms include: frequent headaches that are not relieved by medication, and worsen over time; nausea or vomiting; pain, numbness, or weakness in arms, hands, legs, or feet; seizures; difficulty in walking, talking, or writing; and partial paralysis.

Diagnosis Most brain tumors are detected on the basis of symptoms because there are no screening tests to detect brain tumors early. To detect a brain tumor, a doctor may order a magnetic resonance imaging scan (MRI), which uses magnetic waves to make a picture of the brain. A computed tomography scan (CT), which uses a sophisticated X-ray machine and computer to create a detailed picture of the brain, may be performed instead of an MRI scan.

A Positron Emission Tomography (PET) scan provides a picture of brain activity rather than structure by measuring levels of injected glucose (sugar) or methionine (amino acid) that has been labeled with a radioactive tracer. A PET scan may help a doctor diagnose a recurrent brain tumor that is hard to see on a CT or MRI scan.

Often a biopsy of the tumor tissue is required, or removal of the tumor. In some cases, a lumbar puncture (spinal tap) is performed to provide a definitive diagnosis. For children with a pontine glioma-a deep-seated tumor of the brain stem-doctors use an MRI scan because a biopsy is not considered beneficial.

Once a tumor is found, more tests will be done to determine the type of tumor. To treat a brain tumor, a doctor needs to know how different the tumor cells are from the cells that are near it, which is called the histologic grade of the tumor. Generally, higher-grade tumors look less like the specialized cells they came from and more like unspecialized cells that can divide indefinitely. Such cells are called anaplastic; therefore tumors that are described as anaplastic are often higher grade than those that are not. The grade of the tumor is based solely on the biopsy, but the biopsy may miss higher grade cells lurking nearby. Also, for many patients, the grade of their tumor change during the course of the disease. Because grading a tumor is as much an art as a science, it's essential that a patient have his or her biopsy samples looked at by a neuropathologist who sees a large number of brain tumors.

The most common system for grading gliomas is called the WHO system (because the World Health Organization approves it). In the WHO system, there are four grades of tumors. Grade I tumors are the slowest growing and least aggressive tumors, while grade IV tumors are the fastest growing and most aggressive.There are also other systems used at individual institutions, so it is worth asking a doctor to explain what system he or she is using.

Brain & Nervous System
Your Multidisciplinary Team
Clinical Trials
Patient Education
Contact Us

Make an Appointment
(206) 288-7222

Related Information:
Pediatric Neuro-Oncology Service at the Seattle Cancer Care Alliance
How to Help